Jeffrey J. Brown
Known title: DirectorCIK: 0001245377
Jeffrey J. Brown's purchase track record
How the stock did after each of Jeffrey J. Brown's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
29
of 31 since October 19, 2021
Stock higher 6 months later
31%
3 months: 32%
Median 6-month return
-12.5%
3 months: -4.8%
Beat the S&P 500
21%
median -17.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/7/2026 | UPBD | $46K | -25.1% | pending | — |
| 4/28/2026 | UPBD | $45K | +15.7% | pending | — |
| 1/6/2026 | UPBD | $44K | -4.6% | +14.5% | +8.1% |
| 10/21/2025 | UPBD | $43K | -14.7% | -9.7% | +4.9% |
| 7/8/2025 | UPBD | $43K | -19.5% | -25.8% | +11.6% |
| 5/6/2025 | UPBD | $516K | -6.3% | -12.5% | +20.8% |
| 4/22/2025 | UPBD | $34K | +19.9% | +15.0% | +27.4% |
| 1/7/2025 | UPBD | $33K | -28.8% | -8.0% | +5.4% |
| 10/22/2024 | UPBD | $31K | +7.1% | -25.5% | -9.6% |
| 7/9/2024 | UPBD | $31K | -0.0% | +2.1% | +5.9% |
| 4/22/2024 | UPBD | $30K | +9.1% | -5.0% | +16.8% |
| 1/9/2024 | UPBD | $30K | +4.6% | -7.7% | +17.3% |
| 11/3/2023 | MED | $11K | -24.1% | -61.8% | +17.6% |
| 10/24/2023 | UPBD | $27K | +32.3% | +24.3% | +19.4% |
| 8/4/2023 | MED | $73K | -27.8% | -45.2% | +10.7% |
| 7/11/2023 | UPBD | $27K | -4.8% | +6.0% | +7.1% |
| 5/5/2023 | MED | $69K | +10.7% | -20.1% | +5.4% |
| 4/24/2023 | UPBD | $27K | +45.6% | +18.4% | +1.9% |
| 2/3/2023 | MED | $68K | -20.1% | -11.6% | +8.3% |
| 1/10/2023 | UPBD | $26K | -1.1% | +30.9% | +13.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
No new news for MED in the past week. There are no recent news items specifically about Medifast Inc. in the last seven days. The only recent headlines are about Hormel Foods and Boston Beer, which do not involve Medifast. Therefore, no new developments have been reported for the company itself.
Transaction History
| UPBD | ▲ Buy | Open Market | 454 | $9K | 7/7/2026 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,841 | $37K | 7/7/2026 | View on chart |
| UPBD | ▲ Buy | Open Market | 461 | $9K | 4/28/2026 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,868 | $36K | 4/28/2026 | View on chart |
| UPBD | ▲ Buy | Open Market | 495 | $9K | 1/6/2026 | View on chart |
| UPBD | ▲ Buy | Open Market | 2,007 | $35K | 1/6/2026 | View on chart |
| UPBD | ▲ Buy | Open Market | 386 | $9K | 10/21/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,565 | $35K | 10/21/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 327 | $8K | 7/8/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,326 | $34K | 7/8/2025 | View on chart |
| MED | ▲ Buy | Grant | 11,168 | $0 | 6/25/2025 | View on chart |
| MED | ▲ Buy | Grant | 9,449 | $127K | 6/25/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 21,730 | $516K | 5/6/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,694 | $34K | 4/22/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,146 | $33K | 1/7/2025 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,065 | $31K | 10/22/2024 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,031 | $31K | 7/9/2024 | View on chart |
| MED | ▲ Buy | Grant | 6,596 | $0 | 6/20/2024 | View on chart |
| MED | ▲ Buy | Grant | 5,581 | $126K | 6/20/2024 | View on chart |
| UPBD | ▲ Buy | Open Market | 991 | $30K | 4/22/2024 | View on chart |
| UPBD | ▲ Buy | Open Market | 912 | $30K | 1/9/2024 | View on chart |
| MED | ▲ Buy | Open Market | 58 | $4K | 11/7/2023 | View on chart |
| MED | ▲ Buy | Open Market | 97 | $7K | 11/3/2023 | View on chart |
| UPBD | ▲ Buy | Open Market | 988 | $27K | 10/24/2023 | View on chart |
| MED | ▼ Sell | Open Market | 9,832 | $883K | 8/15/2023 | View on chart |
| MED | ▼ Sell | Open Market | 13,330 | $1.2M | 8/15/2023 | View on chart |
| MED | ▼ Sell | Open Market | 15,154 | $1.4M | 8/14/2023 | View on chart |
| MED | ▲ Buy | Open Market | 44 | $4K | 8/8/2023 | View on chart |
| MED | ▲ Buy | Open Market | 67 | $7K | 8/4/2023 | View on chart |
| MED | ▲ Buy | Open Market | 622 | $62K | 8/4/2023 | View on chart |
| UPBD | ▲ Buy | Open Market | 877 | $27K | 7/11/2023 | View on chart |
| MED | ▲ Buy | Grant | 3,289 | $0 | 6/15/2023 | View on chart |
| MED | ▲ Buy | Open Market | 15 | $1K | 5/9/2023 | View on chart |
| MED | ▲ Buy | Open Market | 681 | $61K | 5/5/2023 | View on chart |
| MED | ▲ Buy | Open Market | 73 | $7K | 5/5/2023 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,143 | $27K | 4/24/2023 | View on chart |
| MED | ▲ Buy | Open Market | 11 | $1K | 2/7/2023 | View on chart |
| MED | ▲ Buy | Open Market | 56 | $6K | 2/3/2023 | View on chart |
| MED | ▲ Buy | Open Market | 516 | $60K | 2/3/2023 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,084 | $26K | 1/10/2023 | View on chart |
| MED | ▲ Buy | Open Market | 12 | $1K | 11/8/2022 | View on chart |
| MED | ▲ Buy | Open Market | 561 | $59K | 11/4/2022 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,475 | $26K | 10/25/2022 | View on chart |
| MED | ▲ Buy | Open Market | 410 | $52K | 8/9/2022 | View on chart |
| MED | ▲ Buy | Open Market | 3,530 | $447K | 8/9/2022 | View on chart |
| MED | ▲ Buy | Grant | 9 | $1K | 8/8/2022 | View on chart |
| MED | ▲ Buy | Open Market | 399 | $58K | 8/4/2022 | View on chart |
| UPBD | ▲ Buy | Open Market | 1,223 | $25K | 7/12/2022 | View on chart |
| MED | ▲ Buy | Grant | 1,580 | $0 | 6/16/2022 | View on chart |
| MED | ▲ Buy | Open Market | 315 | $58K | 5/5/2022 | View on chart |
| UPBD | ▲ Buy | Open Market | 962 | $25K | 4/22/2022 | View on chart |
| MED | ▲ Buy | Open Market | 266 | $50K | 2/4/2022 | View on chart |
| UPBD | ▲ Buy | Open Market | 557 | $25K | 1/13/2022 | View on chart |
| MED | ▲ Buy | Open Market | 807 | $188K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 1,000 | $235K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 600 | $141K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 200 | $44K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 160 | $36K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 200 | $45K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 200 | $46K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 150 | $35K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 290 | $67K | 11/8/2021 | View on chart |
| MED | ▲ Buy | Open Market | 593 | $139K | 11/8/2021 | View on chart |
| UPBD | ▲ Buy | Open Market | 24,330 | $1.1M | 11/8/2021 | View on chart |
| UPBD | ▲ Buy | Open Market | 277 | $15K | 10/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Upbound Group sets date for Q3 2026 earnings release
Upbound Group has announced the timing for its third-quarter 2026 financial results. This standard corporate disclosure allows investors to prepare for the upcoming earnings report. The company's stock is currently trading with a low RSI, suggesting recent selling pressure, while maintaining a dividend yield of 4.63%.
Upbound Group sets date for Q3 2026 earnings release. Upbound Group has announced the timing for its third-quarter 2026 financial results. This standard corporate disclosure allows investors to prepare for the upcoming earnings report. The company's stock is currently trading with a low RSI, suggesting recent selling pressure, while maintaining a dividend yield of 4.63%.